Original Article
Original Article
/ VOLUME 5, ISSUE 3, SEPTEMBER 2023
Nuriye Yalçın-Çolak and others
COVID-19, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a zoonotic infection that emerged in Wuhan province of China in December 2019. SARS-COV-2 is a Betacoronavirus that is classified in Riboviria realm, Nidovirales order, and Coronaviridae family (1). Although the fatality rate of SARS-CoV-2 (2.6%) is lower than SARS-CoV (11%) and MERS-CoV (35-50%), it was much more severe worldwide (...) Read More
Original Article
/ VOLUME 5, ISSUE 3, SEPTEMBER 2023
Sevil Alkan and Esra Gürbüz
Middle East Respiratory Syndrome (MERS) is a viral respiratory infection caused by the MERS coronavirus (MERS-CoV) from the Coronaviridae family. MERS coronavirus was first identified as the etiologic agent from a patient living in Saudi Arabia in 2012, and it is the sixth human coronavirus . After the first case, the infection was detected in Bahrain, Iran, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, the United Arab Emirates, and Yemen. So far, all MERS-CoV cases worldwide have been associated with a travel history (...) Read More
Original Article
/ VOLUME 5, ISSUE 3, SEPTEMBER 2023
Hüseyin Bilgin and others
Hospital-acquired respiratory viral infections are associated with increased mortality and morbidity and prolonged hospital stays (1). Hospital-acquired influenza (HAI) accounts for 10-15% of these infections (2-4). Previous studies reported the proportion of HAI to influenza-diagnosed patients admitted to the hospital between 4%-25% (5-8). A systematic review showed that the average proportion of HAI among all hospitalized (...) Read More
Original Article
/ VOLUME 5, ISSUE 3, SEPTEMBER 2023
Yusuf Emre Özdemir and others
Burkholderia cepacia complex is aerobic, non-fermentative, multi-drug resistant Gram-negative bacilli containing 24 opportunistic pathogenic species (1). B. cepacia complex members are commonly found in natural environments because they easily adapt to harsh environments due to their genotypic and phenotypic plasticity and ability to mutate rapidly. B. cepacia complex can also grow substantially and survive in water-based (...) Read More
Original Article
/ VOLUME 5, ISSUE 2, JUNE 2023
Uluhan Sili* and others
The first coronavirus disease 2019 (COVID-19) case in Turkey was reported on March 11, 2020. The number of confirmed cases with symptoms increased afterward, reaching 5000 per day by mid-April. With the effect of mitigation measures, the number of daily cases started to decline, (...) Read More
Original Article
/ VOLUME 5, ISSUE 2, JUNE 2023
Mustafa Güldan and others
The coronavirus disease 2019 (COVID-19) caused more than 6 million deaths worldwide, and vaccination remains to be the most effective way to reduce the deaths in addition to infection control measures in the community. The Turkish Ministry of Health offered two types of vaccines (...) Read More
Original Article
/ VOLUME 5, ISSUE 2, JUNE 2023
Reza Kamali Kakhki* and others
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory disease agent belonging to the Betacoronavirus genera. The genome of the virus translates into four major structural proteins, including spike (S), nucleocapsid (N), membrane (M), and envelop (E) proteins. During the pandemic, huge numbers of mutations (...) Read More
Original Article
/ VOLUME 5, ISSUE 2, JUNE 2023
Yeşim Yıldız and others
Vaccines to prevent SARS-CoV-2 infection are the most promising and effective approach to curb the COVID-19 pandemic, as well as to reduce hospitalizations and prevent mortality. In our country, the CoronaVac (Sinovac Biotech, China) vaccine started to be administered as of January 13, 2021, and the Comirnaty (BNT162b2, Pfizer-BioNTech) vaccine as (...) Read More
Original Article
/ VOLUME 5, ISSUE 2, JUNE 2023
Özge Kaya and others
Psoriasis, a chronic inflammatory disease, has a multifactorial etiology, including genetic, environmental, and behavioral factors. Since psoriasis is an immune system-mediated disease, immunosuppressive agents and biological treatments are frequently used in its treatment; however, these agents are known to increase the risk of infection. This situation (...) Read More
Original Article
/ VOLUME 5, ISSUE 2, JUNE 2023
Murat Erdem and others
The standard method to detect SARS-CoV-2 has been real-time polymerase chain reaction (RT-PCR). Regardless of its high sensitivity and specificity, this method has some drawbacks as it requires complex and expensive equipment, extensive user training, (...) Read More
Original Article
/ VOLUME 5, ISSUE 2, JUNE 2023
Betül Çopur and others
COVID-19 is a fatal disease affecting all systems, especially the respiratory system. It manifests with different clinical characteristics, from asymptomatic infection to severe infection. Since its initial description, the disease has caused devastating effects and many deaths. Predictors of mortality (...) Read More
Original Article
/ VOLUME 5, ISSUE 2, JUNE 2023
Meyha Şahin and Meltem Yazla
Chronic hepatitis B virus (HBV) infection is a serious public health problem affecting 257 million people worldwide (3.5% of the world population), according to World Health Statistics 2015 by the World Health Organization (WHO). In Turkey, approximately 3.3 million people (4.57% of the population) are considered HBsAg (hepatitis B surface antigen) positive (...) Read More
Original Article
/ VOLUME 5, ISSUE 2, JUNE 2023
Oruç Numan Gökçe and others
Many parts of the world are affected by Echinococcus granulosus. This helminthic zoonosis leads to important public health and economic burdens in endemic regions. E. granulosus can even lead to death if complications occur. Dogs are the definitive hosts of E. granulosus, where the larval state, (...) Read More
Original Article
/ VOLUME 5, ISSUE 1, MARCH 2023
Çaşıt Olgun Çelik and others
An acute respiratory syndrome (COVID-19), caused by a novel coronavirus (SARS-CoV-2), has spread from China worldwide and caused a pandemic that brought severe medical, social, and economic problems. The COVID-19 infection results in various clinical presentations ranging from an asymptomatic (...) Read More
Original Article
/ VOLUME 5, ISSUE 1, MARCH 2023
Aynur Atilla and others
Fournier’s gangrene (FG) is necrotizing fasciitis of genital or perianal areas. Typically, FG is an infection of polymicrobial origin and has higher mortality rates if treatment is not initiated earlier. The main etiological factors are colorectal (30%-50%) and genitourinary origins (20%-40%), including anorectal infections, (...) Read More
Original Article
/ VOLUME 5, ISSUE 1, MARCH 2023
Esma Eryılmaz-Eren and others
Coronavirus disease (COVID-19) has caused more than 660 million cases and more than six million deaths worldwide (1). COVID-19 can cause different clinical situations ranging from asymptomatic to life-threatening infections. Patients (...) Read More
Original Article
/ VOLUME 5, ISSUE 1, MARCH 2023
Tuğba Yanık-Yalçın and others
Staphylococcus aureus colonizes the skin and mucosa of humans. Infections because of S. aureus can range from skin infections to potentially fatal conditions like pneumonia, sepsis, and endocarditis. S. aureus is a common cause of nosocomial and community-acquired bloodstream infections worldwide. Because of biofilm (...) Read More
Original Article
/ VOLUME 5, ISSUE 1, MARCH 2023
Çiğdem Erol and others
Candida species are major sources of morbidity and mortality in healthcare settings. These infections are predominantly connected with medical procedures. The five most prevalent pathogens- Candida albicans, Candida glabrata, Candida tropicalis, Candida parapsilosis, and Candida krusei – are responsible for (...) Read More
Original Article
/ VOLUME 4, ISSUE 4, DECEMBER 2022
Hande Özportakal and others
The world has been fighting against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for more than two years, leading to more than 605 million cases and 6.4 million deaths as of September 11, 2022. Since the angiotensin-converting enzyme (ACE) is the functional receptor for SARS-CoV-2, predominantly expressed by the alveoli (...) Read More
Original Article
/ VOLUME 4, ISSUE 4, DECEMBER 2022
Mehmet Gökhan Gönenli and others
Healthcare workers were on the front line of the global effort against COVID-19. Thousands of physicians died from COVID-19 in many countries. In addition, difficulties in accessing personal protective equipment (PPE), lack of training, and workforce shortages have exposed the vulnerability of healthcare workers who desperately sought other options to protect (...) Read More